S
ADVM

SignatureFD’s Adverum Biotechnologies ADVM Stock Holding History

SignatureFD’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-184
Closed -$4K – 3085
2021
Q3 		$4K Sell
184
-60
-25% -$1.53K ﹤0.01% 2405
2021
Q2 		$9K Buy
244
+77
+46% +$4.15K ﹤0.01% 2013
2021
Q1 		$16K Hold
167
– – ﹤0.01% 1644
2020
Q4 		$18K Sell
167
-150
-47% -$18.6K ﹤0.01% 1483
2020
Q3 		$33K Hold
317
– – ﹤0.01% 1152
2020
Q2 		$66K Buy
317
+300
+1,765% +$53.1K ﹤0.01% 842
2020
Q1 		$2K Buy
+17
New +$1.98K ﹤0.01% 1893

Other funds holding ADVM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SignatureFD's ADVM Position: Q4 2021 in Review

SignatureFD sold out of Adverum Biotechnologies (ADVM) in Q4 2021, closing a stake of 184 shares — an estimated $4K sold.

SignatureFD first reported a position in ADVM in Q1 2020 and held it in 7 quarters. The position peaked at $66K in Q2 2020. 98 funds tracked by Wall St. Rank hold ADVM as of Q4 2021.

  • SignatureFD reported no remaining Adverum Biotechnologies position as of Q4 2021 after selling out during the quarter.
  • SignatureFD sold 184 Adverum Biotechnologies shares in Q4 2021, an estimated $4K.
  • SignatureFD first reported a position in Adverum Biotechnologies in Q1 2020 and held it in 7 quarters.
  • SignatureFD's Adverum Biotechnologies position peaked at $66K in Q2 2020.
  • 98 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2021.

Based on SignatureFD's 13F filing for Q4 2021, filed 25 Jan 2022.